Compare $DYAI vs $JSPR | Chartloom

Compare

$DYAI vs $JSPR

Dyadic International Inc · Jasper Therapeutics Inc

DYAI

Dyadic International Inc

JSPR

Jasper Therapeutics Inc

Compare $DYAI vs $JSPR

Comparing Dyadic International Inc and Jasper Therapeutics Inc

DYAIDyadic International Inc

JSPRJasper Therapeutics Inc

DYAIDyadic International Inc

Market cap

$16M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.15x

Rev growth (TTM)

-8.1%

YTD performance

-52.8%

52W performance

-60.7%

FCF yield

-45.8%

JSPRJasper Therapeutics Inc

Market cap

$19M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-69.0%

52W performance

-76.2%

FCF yield

-318.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DYAI

JSPR

Detailed metrics comparison

DYAI

Dyadic International Inc

JSPR

Jasper Therapeutics Inc

Market Cap

DYAI$16M

JSPR$19M

Enterprise Value

DYAI$20M

JSPR$12M

Price

DYAI$0.44

JSPR$0.57

P/E Ratio

DYAIN/A

JSPRN/A

P/S Ratio

DYAI4.26x

JSPR0.00x

EV/Sales

DYAI5.21x

JSPR0.00x

EV/EBITDA

DYAI75.44x

JSPR0.00x

P/B Ratio

DYAI14.82x

JSPR13.31x

P/FCF Ratio

DYAIN/A

JSPRN/A

EV/FCF

DYAI-2.67x

JSPR-0.19x

PEG Ratio

DYAIN/A

JSPRN/A

Forward P/E (NTM)

DYAIN/A

JSPRN/A

Forward P/S (NTM)

DYAI2.15x

JSPRN/A

Revenue (TTM)

DYAI$4M

JSPR$0

Revenue Growth (YoY)

DYAI-8.1%

JSPRN/A

Forward Rev Growth

DYAI91.1%

JSPR-81.1%

Gross Margin (TTM)

DYAI16.2%

JSPR0.0%

Operating Margin (TTM)

DYAI0.0%

JSPR0.0%

EBITDA Margin (TTM)

DYAI-194.5%

JSPR0.0%

Net Margin (TTM)

DYAI-200.5%

JSPR0.0%

FCF Margin (TTM)

DYAI-194.7%

JSPRN/A

Net Income (TTM)

DYAI$-8M

JSPR$-32M

FCF (TTM)

DYAI$-7M

JSPR$-60M

EPS (TTM)

DYAI-$0.21

JSPR-$1.11

ROE (TTM)

DYAI-35086.0%

JSPR-61887.0%

ROA (TTM)

DYAI-8477.0%

JSPR-10067.0%

ROIC (TTM)

DYAI-8444.0%

JSPR-61887.0%

Cash

DYAI$1M

JSPR$7M

Debt

DYAI$5M

JSPR$0

Net Cash/Debt

DYAI$-4M

JSPR$7M

Current Ratio (TTM)

DYAI1.65x

JSPR1.48x

Quick Ratio (TTM)

DYAI1.54x

JSPR1.02x

Debt/Equity (TTM)

DYAI4.08x

JSPR0.00x

Debt/Assets (TTM)

DYAI0.0%

JSPR0.0%

Interest Coverage (TTM)

DYAIN/A

JSPRN/A

Net Debt/EBITDA (TTM)

DYAI0.00x

JSPR0.00x

Beta

DYAI1.09

JSPR3.37

52W Performance

DYAI-60.7%

JSPR-76.2%

YTD Performance

DYAI-52.8%

JSPR-69.0%

% from 52W High

DYAI-72.2%

JSPR-78.8%

% from 52W Low

DYAI30.6%

JSPR81.0%

Asset Turnover (TTM)

DYAI0.42x

JSPR0.00x

FCF Yield (TTM)

DYAI-45.8%

JSPR-318.0%

Earnings Yield (TTM)

DYAI-47.1%

JSPR-167.5%

Dividend Yield (TTM)

DYAIN/A

JSPRN/A

Rule of 40

DYAI-202.8

JSPR0.0

EV/GP/RG

DYAI0.30

JSPRN/A

Ticker research

View DYAI research View JSPR research

Metric	DYAI Dyadic International Inc	JSPR Jasper Therapeutics Inc
Market & Valuation
Market Cap	$16M	$19M
Enterprise Value	$20M	$12M
Price	$0.44	$0.57
P/E Ratio	N/A	N/A
P/S Ratio	4.26x	0.00x
EV/Sales	5.21x	0.00x
EV/EBITDA	75.44x	0.00x
P/B Ratio	14.82x	13.31x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.67x	-0.19x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	2.15x	N/A
Revenue & Growth
Revenue (TTM)	$4M	$0
Revenue Growth (YoY)	-8.1%	N/A
Forward Rev Growth	91.1%	-81.1%
Profitability
Gross Margin (TTM)	16.2%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-194.5%	0.0%
Net Margin (TTM)	-200.5%	0.0%
FCF Margin (TTM)	-194.7%	N/A
Net Income (TTM)	$-8M	$-32M
FCF (TTM)	$-7M	$-60M
EPS (TTM)	-$0.21	-$1.11
ROE (TTM)	-35086.0%	-61887.0%
ROA (TTM)	-8477.0%	-10067.0%
ROIC (TTM)	-8444.0%	-61887.0%
Financial Health
Cash	$1M	$7M
Debt	$5M	$0
Net Cash/Debt	$-4M	$7M
Current Ratio (TTM)	1.65x	1.48x
Quick Ratio (TTM)	1.54x	1.02x
Debt/Equity (TTM)	4.08x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.09	3.37
52W Performance	-60.7%	-76.2%
YTD Performance	-52.8%	-69.0%
% from 52W High	-72.2%	-78.8%
% from 52W Low	30.6%	81.0%
Efficiency & Yields
Asset Turnover (TTM)	0.42x	0.00x
FCF Yield (TTM)	-45.8%	-318.0%
Earnings Yield (TTM)	-47.1%	-167.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-202.8	0.0
EV/GP/RG	0.30	N/A
Ticker research	View DYAI research	View JSPR research

Valuation

P/S Ratio

JSPR

0.00x

DYAI

4.26x

EV/FCF

DYAI

-2.67x

JSPR

-0.19x

Growth & revenue

Revenue Growth TTM

DYAI

-8.1%

Forward Revenue Growth

DYAI

91.1%

JSPR

-81.1%

Profitability & performance

Gross Margin

DYAI

16.2%

JSPR

0.0%

ROE

DYAI

-35086.0%

JSPR

-61887.0%

FCF Yield %

DYAI

-45.8%

JSPR

-318.0%

52-Week Performance

DYAI

-60.7%

JSPR

-76.2%

Detailed metrics comparison

DYAI

Dyadic International Inc

JSPR

Jasper Therapeutics Inc

Market Cap

DYAI$16M

JSPR$19M

Enterprise Value

DYAI$20M

JSPR$12M

Price

DYAI$0.44

JSPR$0.57

P/E Ratio

DYAIN/A

JSPRN/A

P/S Ratio

DYAI4.26x

JSPR0.00x

EV/Sales

DYAI5.21x

JSPR0.00x

EV/EBITDA

DYAI75.44x

JSPR0.00x

P/B Ratio

DYAI14.82x

JSPR13.31x

P/FCF Ratio

DYAIN/A

JSPRN/A

EV/FCF

DYAI-2.67x

JSPR-0.19x

PEG Ratio

DYAIN/A

JSPRN/A

Forward P/E (NTM)

DYAIN/A

JSPRN/A

Forward P/S (NTM)

DYAI2.15x

JSPRN/A

Revenue (TTM)

DYAI$4M

JSPR$0

Revenue Growth (YoY)

DYAI-8.1%

JSPRN/A

Forward Rev Growth

DYAI91.1%

JSPR-81.1%

Gross Margin (TTM)

DYAI16.2%

JSPR0.0%

Operating Margin (TTM)

DYAI0.0%

JSPR0.0%

EBITDA Margin (TTM)

DYAI-194.5%

JSPR0.0%

Net Margin (TTM)

DYAI-200.5%

JSPR0.0%

FCF Margin (TTM)

DYAI-194.7%

JSPRN/A

Net Income (TTM)

DYAI$-8M

JSPR$-32M

FCF (TTM)

DYAI$-7M

JSPR$-60M

EPS (TTM)

DYAI-$0.21

JSPR-$1.11

ROE (TTM)

DYAI-35086.0%

JSPR-61887.0%

ROA (TTM)

DYAI-8477.0%

JSPR-10067.0%

ROIC (TTM)

DYAI-8444.0%

JSPR-61887.0%

Cash

DYAI$1M

JSPR$7M

Debt

DYAI$5M

JSPR$0

Net Cash/Debt

DYAI$-4M

JSPR$7M

Current Ratio (TTM)

DYAI1.65x

JSPR1.48x

Quick Ratio (TTM)

DYAI1.54x

JSPR1.02x

Debt/Equity (TTM)

DYAI4.08x

JSPR0.00x

Debt/Assets (TTM)

DYAI0.0%

JSPR0.0%

Interest Coverage (TTM)

DYAIN/A

JSPRN/A

Net Debt/EBITDA (TTM)

DYAI0.00x

JSPR0.00x

Beta

DYAI1.09

JSPR3.37

52W Performance

DYAI-60.7%

JSPR-76.2%

YTD Performance

DYAI-52.8%

JSPR-69.0%

% from 52W High

DYAI-72.2%

JSPR-78.8%

% from 52W Low

DYAI30.6%

JSPR81.0%

Asset Turnover (TTM)

DYAI0.42x

JSPR0.00x

FCF Yield (TTM)

DYAI-45.8%

JSPR-318.0%

Earnings Yield (TTM)

DYAI-47.1%

JSPR-167.5%

Dividend Yield (TTM)

DYAIN/A

JSPRN/A

Rule of 40

DYAI-202.8

JSPR0.0

EV/GP/RG

DYAI0.30

JSPRN/A

Ticker research

View DYAI research View JSPR research

Metric	DYAI Dyadic International Inc	JSPR Jasper Therapeutics Inc
Market & Valuation
Market Cap	$16M	$19M
Enterprise Value	$20M	$12M
Price	$0.44	$0.57
P/E Ratio	N/A	N/A
P/S Ratio	4.26x	0.00x
EV/Sales	5.21x	0.00x
EV/EBITDA	75.44x	0.00x
P/B Ratio	14.82x	13.31x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.67x	-0.19x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	2.15x	N/A
Revenue & Growth
Revenue (TTM)	$4M	$0
Revenue Growth (YoY)	-8.1%	N/A
Forward Rev Growth	91.1%	-81.1%
Profitability
Gross Margin (TTM)	16.2%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-194.5%	0.0%
Net Margin (TTM)	-200.5%	0.0%
FCF Margin (TTM)	-194.7%	N/A
Net Income (TTM)	$-8M	$-32M
FCF (TTM)	$-7M	$-60M
EPS (TTM)	-$0.21	-$1.11
ROE (TTM)	-35086.0%	-61887.0%
ROA (TTM)	-8477.0%	-10067.0%
ROIC (TTM)	-8444.0%	-61887.0%
Financial Health
Cash	$1M	$7M
Debt	$5M	$0
Net Cash/Debt	$-4M	$7M
Current Ratio (TTM)	1.65x	1.48x
Quick Ratio (TTM)	1.54x	1.02x
Debt/Equity (TTM)	4.08x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.09	3.37
52W Performance	-60.7%	-76.2%
YTD Performance	-52.8%	-69.0%
% from 52W High	-72.2%	-78.8%
% from 52W Low	30.6%	81.0%
Efficiency & Yields
Asset Turnover (TTM)	0.42x	0.00x
FCF Yield (TTM)	-45.8%	-318.0%
Earnings Yield (TTM)	-47.1%	-167.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-202.8	0.0
EV/GP/RG	0.30	N/A
Ticker research	View DYAI research	View JSPR research